CSIMarket
 


Y mabs Therapeutics inc   (YMAB)
Other Ticker:  
 


Y Mabs Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



YMAB Gross Profit Margin (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Revenue Change 63.15 % 92.19 % 93.12 % 227.64 % 39.84 %
Seq. Revenue Change -1.43 % 2.47 % -35.6 % 150.83 % 16.12 %
Revenue In Millions $20.45 $20.75 $20.25 $31.45 $12.54
Gross Profit Margin 87.31 % 77.6 % 89.71 % 93.57 % 80.26 %
Gross Profit Margin Total Ranking # 1186 # 1552 # 1239 # 1393 # 1554
Gross Profit In Millions $17.86 $16.10 $18.17 $29.43 $10.06
Y / Y Gross Profit Change 77.49 % 66.74 % 109.91 % 261.63 % 19.57 %
Seq. Gross Profit Change 10.91 % -11.37 % -38.26 % 192.45 % 4.19 %


Commenting Third Quarter 2023 Gross Profit Margin
Despite the sequential Revenue deterioration in III. Quarter of -1.43 % Y mabs Therapeutics inc managed to reduce Cost of Sales and increase Gross Profit by 10.91 % to $18 millions. Gross Profit Margin grew to 87.31 %, below company average Gross Profit Margin.

Observing third quarter 2023 results within Major Pharmaceutical Preparations industry 164 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 1186, from total ranking in previous quarter at 1552.
Learn about Gross Margin
YMAB's Gross Profit Margin third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 165
Healthcare Sector # 286
Overall # 1181

Gross Profit Margin Statistics
High Average Low
98.27 % 88.68 % 77.6 %
(Mar 31 2021)   (Jun 30 2023)




Other Gross Profit Margin Profitability Ratios
YMAB's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
YMAB's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for YMAB's Competitors
Gross Profit Margin Profit Margin for Y Mabs Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for YMAB's Customers

You may also want to know
YMAB's Annual Growth Rates YMAB's Profitability Ratios YMAB's Asset Turnover Ratio YMAB's Dividend Growth
YMAB's Roe YMAB's Valuation Ratios YMAB's Financial Strength Ratios YMAB's Gross Profit Growth
YMAB's Roa YMAB's Inventory Turnover Ratio YMAB's Growth Rates YMAB's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Gross Profit MarginSep 30 2023 MRQ Gross ProfitSep 30 2023 MRQ Revenue
Abcellera Biologics Inc   100.00 %$ 6.599 $ 6.599 
Abeona Therapeutics Inc   100.00 %$ 0.593 $ 0.593 
Arbutus Biopharma Corp  100.00 %$ 4.658 $ 4.658 
Alpine Immune Sciences Inc   100.00 %$ 10.043 $ 10.043 
Altimmune Inc   100.00 %$ 0.362 $ 0.362 
Anaptysbio Inc   100.00 %$ 3.318 $ 3.318 
Apellis Pharmaceuticals Inc   100.00 %$ 110.399 $ 110.399 
Aravive Inc   100.00 %$ 2.756 $ 2.756 
Arcturus Therapeutics Holdings Inc   100.00 %$ 45.140 $ 45.140 
Aridis Pharmaceuticals Inc   100.00 %$ 0.417 $ 0.417 
Arvinas Inc   100.00 %$ 34.600 $ 34.600 
Arrowhead Pharmaceuticals Inc   100.00 %$ 16.097 $ 16.097 
Atai Life Sciences N v   100.00 %$ 0.087 $ 0.087 
Axim Biotechnologies Inc   100.00 %$ 0.010 $ 0.010 
Azitra Inc   100.00 %$ 0.311 $ 0.311 
Bicycle Therapeutics Plc  100.00 %$ 5.352 $ 5.352 
Bellicum Pharmaceuticals Inc   100.00 %$ 1.002 $ 1.002 
Bolt Biotherapeutics Inc   100.00 %$ 2.528 $ 2.528 
Capricor Therapeutics inc   100.00 %$ 6.186 $ 6.186 
Carisma Therapeutics Inc   100.00 %$ 3.827 $ 3.827 
Checkpoint Therapeutics Inc   100.00 %$ 0.031 $ 0.031 
Chimerix Inc   100.00 %$ 0.011 $ 0.011 
Cnbx Pharmaceuticals Inc   100.00 %$ 0.100 $ 0.100 
Cns Pharmaceuticals Inc   100.00 %$ 0.013 $ 0.013 
Crinetics Pharmaceuticals Inc   100.00 %$ 0.346 $ 0.346 
Cervomed Inc   100.00 %$ 1.526 $ 1.526 
Cytomx Therapeutics Inc   100.00 %$ 26.384 $ 26.384 
Cue Biopharma Inc   100.00 %$ 2.100 $ 2.100 
Cyclacel Pharmaceuticals Inc   100.00 %$ 0.016 $ 0.016 
Cytokinetics Incorporated  100.00 %$ 0.378 $ 0.378 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com